Carmot Therapeutics Inc.
Records under this name other than the patents Carmot Therapeutics Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Back to Carmot Therapeutics Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,572,374 | N-CYANO-7-Azanorbornane Derivatives and Uses Thereof now held by Amgen Inc. In force · High confidence | In force | High confidence | |
| 17/586,751 | GPCR Receptor Agonists, Pharmaceutical Compositions Comprising the Same, and Methods for Their Use Abandoned Abandoned Nov 7, 2023 | Abandoned | Abandoned Nov 7, 2023 | |
| 17/736,070 | Benzimidazoyl GLP-1 Receptor Agonists, Pharmaceutical Compositions Comprising the Same, and Methods for Their Use Abandoned Abandoned Apr 25, 2025 | Abandoned | Abandoned Apr 25, 2025 | |
| 18/087,063 | Modulators of G-Protein Coupled Receptors Abandoned Abandoned Mar 27, 2025 | Abandoned | Abandoned Mar 27, 2025 | |
| 18/240,763 | GLP-1 Receptor Agonists, Pharmaceutical Compositions Comprising the Same, and Methods for Their Use Abandoned Abandoned Apr 15, 2024 | Abandoned | Abandoned Apr 15, 2024 | |
| 18/262,956 | GPCR Receptor Agonists, Pharmaceutical Compositions Comprising the Same, and Methods for Their Use Abandoned Abandoned May 7, 2025 | Abandoned | Abandoned May 7, 2025 | |
| 18/558,647 | Benzimidazoyl GLP-1 Receptor Agonists, Pharmaceutical Compositions Comprising the Same, and Methods for Their Use Abandoned Abandoned Aug 25, 2026 | Abandoned | Abandoned Aug 25, 2026 | |
| 18/632,736 | GPCR Receptor Agonists, Pharmaceutical Compositions Comprising the Same, and Methods for Their Use Abandoned Abandoned May 7, 2025 | Abandoned | Abandoned May 7, 2025 | |
| 18/644,041 | Treatment of Diabetes Mellitus Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/670,592 | Treatment of Adults With Overweight or Obesity With or Without Weight-Related Comorbidities Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. |